BIOMERIEUX (BIM.PA) Stock Fundamental Analysis
EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 55 industry peers in the Health Care Equipment & Supplies industry. BIM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BIM has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year BIM was profitable.
BIM had a positive operating cash flow in the past year.
In the past 5 years BIM has always been profitable.
BIM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BIM has a better Return On Assets (7.73%) than 83.64% of its industry peers.
The Return On Equity of BIM (10.63%) is better than 80.00% of its industry peers.
The Return On Invested Capital of BIM (8.96%) is better than 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BIM is above the industry average of 8.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.73% | ||
| ROE | 10.63% | ||
| ROIC | 8.96% |
ROA(3y)9.53%
ROA(5y)9.22%
ROE(3y)13.8%
ROE(5y)14.08%
ROIC(3y)11.57%
ROIC(5y)11.82%
1.3 Margins
BIM has a better Profit Margin (10.81%) than 78.18% of its industry peers.
BIM's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 13.65%, BIM is doing good in the industry, outperforming 78.18% of the companies in the same industry.
In the last couple of years the Operating Margin of BIM has declined.
With a Gross Margin value of 55.72%, BIM perfoms like the industry average, outperforming 52.73% of the companies in the same industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.65% | ||
| PM (TTM) | 10.81% | ||
| GM | 55.72% |
OM growth 3Y-12.33%
OM growth 5Y-3.52%
PM growth 3Y-9.13%
PM growth 5Y-1.68%
GM growth 3Y-0.15%
GM growth 5Y0.81%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BIM is still creating some value.
The number of shares outstanding for BIM remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BIM has more shares outstanding
The debt/assets ratio for BIM is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 7.00 indicates that BIM is not in any danger for bankruptcy at the moment.
The Altman-Z score of BIM (7.00) is better than 96.36% of its industry peers.
BIM has a debt to FCF ratio of 3.57. This is a good value and a sign of high solvency as BIM would need 3.57 years to pay back of all of its debts.
BIM's Debt to FCF ratio of 3.57 is amongst the best of the industry. BIM outperforms 81.82% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that BIM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, BIM belongs to the top of the industry, outperforming 83.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 3.57 | ||
| Altman-Z | 7 |
ROIC/WACC1.15
WACC7.81%
2.3 Liquidity
BIM has a Current Ratio of 2.21. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
BIM has a better Current ratio (2.21) than 67.27% of its industry peers.
A Quick Ratio of 1.20 indicates that BIM should not have too much problems paying its short term obligations.
BIM has a better Quick ratio (1.20) than 65.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.54% over the past year.
BIM shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.76% yearly.
BIM shows a small growth in Revenue. In the last year, the Revenue has grown by 2.85%.
BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.70% yearly.
EPS 1Y (TTM)6.54%
EPS 3Y-4.07%
EPS 5Y6.76%
EPS Q2Q%33.49%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y5.63%
Revenue growth 5Y8.7%
Sales Q2Q%7.45%
3.2 Future
Based on estimates for the next years, BIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.07% on average per year.
Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 7.82% on average per year.
EPS Next Y11.38%
EPS Next 2Y11.53%
EPS Next 3Y12.2%
EPS Next 5Y13.07%
Revenue Next Year7.52%
Revenue Next 2Y7.68%
Revenue Next 3Y7.7%
Revenue Next 5Y7.82%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
BIM is valuated quite expensively with a Price/Earnings ratio of 33.32.
BIM's Price/Earnings ratio is a bit cheaper when compared to the industry. BIM is cheaper than 67.27% of the companies in the same industry.
BIM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.05 indicates a quite expensive valuation of BIM.
BIM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BIM is cheaper than 63.64% of the companies in the same industry.
BIM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.32 | ||
| Fwd PE | 25.05 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than 69.09% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as BIM.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 87.26 | ||
| EV/EBITDA | 18.47 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
BIM's earnings are expected to grow with 12.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.93
PEG (5Y)4.93
EPS Next 2Y11.53%
EPS Next 3Y12.2%
5. Dividend
5.1 Amount
BIM has a yearly dividend return of 0.74%, which is pretty low.
Compared to an average industry Dividend Yield of 2.13, BIM pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, BIM's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.74% |
5.2 History
The dividend of BIM is nicely growing with an annual growth rate of 20.02%!
Dividend Growth(5Y)20.02%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
24.36% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP24.36%
EPS Next 2Y11.53%
EPS Next 3Y12.2%
EPA:BIM (3/7/2025, 7:00:00 PM)
115.3
+0.8 (+0.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners20.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.65B
Analysts76.84
Price Target126.23 (9.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.74% |
Yearly Dividend0.85
Dividend Growth(5Y)20.02%
DP24.36%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.59%
PT rev (3m)3.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.41%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.32 | ||
| Fwd PE | 25.05 | ||
| P/S | 3.59 | ||
| P/FCF | 87.26 | ||
| P/OCF | 27.59 | ||
| P/B | 3.53 | ||
| P/tB | 5.2 | ||
| EV/EBITDA | 18.47 |
EPS(TTM)3.46
EY3%
EPS(NY)4.6
Fwd EY3.99%
FCF(TTM)1.32
FCFY1.15%
OCF(TTM)4.18
OCFY3.62%
SpS32.16
BVpS32.68
TBVpS22.16
PEG (NY)2.93
PEG (5Y)4.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.73% | ||
| ROE | 10.63% | ||
| ROCE | 12.03% | ||
| ROIC | 8.96% | ||
| ROICexc | 9.56% | ||
| ROICexgc | 13.78% | ||
| OM | 13.65% | ||
| PM (TTM) | 10.81% | ||
| GM | 55.72% | ||
| FCFM | 4.11% |
ROA(3y)9.53%
ROA(5y)9.22%
ROE(3y)13.8%
ROE(5y)14.08%
ROIC(3y)11.57%
ROIC(5y)11.82%
ROICexc(3y)13.89%
ROICexc(5y)13.87%
ROICexgc(3y)22.31%
ROICexgc(5y)23.43%
ROCE(3y)15.5%
ROCE(5y)15.82%
ROICexcg growth 3Y-22%
ROICexcg growth 5Y-8.85%
ROICexc growth 3Y-18.45%
ROICexc growth 5Y-4.35%
OM growth 3Y-12.33%
OM growth 5Y-3.52%
PM growth 3Y-9.13%
PM growth 5Y-1.68%
GM growth 3Y-0.15%
GM growth 5Y0.81%
F-Score6
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 3.57 | ||
| Debt/EBITDA | 0.52 | ||
| Cap/Depr | 144.59% | ||
| Cap/Sales | 8.88% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 65.65% | ||
| Profit Quality | 38.03% | ||
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 7 |
F-Score6
WACC7.81%
ROIC/WACC1.15
Cap/Depr(3y)358.73%
Cap/Depr(5y)270.32%
Cap/Sales(3y)8.6%
Cap/Sales(5y)8.97%
Profit Quality(3y)53.51%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)6.54%
EPS 3Y-4.07%
EPS 5Y6.76%
EPS Q2Q%33.49%
EPS Next Y11.38%
EPS Next 2Y11.53%
EPS Next 3Y12.2%
EPS Next 5Y13.07%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y5.63%
Revenue growth 5Y8.7%
Sales Q2Q%7.45%
Revenue Next Year7.52%
Revenue Next 2Y7.68%
Revenue Next 3Y7.7%
Revenue Next 5Y7.82%
EBIT growth 1Y4.34%
EBIT growth 3Y-7.4%
EBIT growth 5Y4.87%
EBIT Next Year62.06%
EBIT Next 3Y26.65%
EBIT Next 5Y20.47%
FCF growth 1Y-59.94%
FCF growth 3Y-29.47%
FCF growth 5Y-9.18%
OCF growth 1Y-28.3%
OCF growth 3Y-8.57%
OCF growth 5Y2.19%